{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:11:37Z","timestamp":1790770297725,"version":"4.1.0"},"reference-count":42,"publisher":"Cambridge University Press (CUP)","issue":"5","license":[{"start":{"date-parts":[[2007,6,22]],"date-time":"2007-06-22T00:00:00Z","timestamp":1182470400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epidemiol. Infect."],"published-print":{"date-parts":[[2008,5]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>Lyssaviruses cause acute, progressive encephalitis in mammals. Current rabies vaccines offer protection against the lyssaviruses, with the notable exceptions of Mokola virus (MOKV), Lagos bat virus (LBV) and West Caucasian bat virus (WCBV). Here we describe the cross-protective and cross-reactive immune responses induced by experimental recombinant vaccinia viruses encoding the glycoprotein genes of rabies virus (RABV), MOKV and WCBV, either singly or in dual combinations. Constructs expressing a single glycoprotein gene protected mice against lethal intracranial challenge with homologous virus. Similarly, recombinants expressing glycoprotein genes from two different lyssaviruses offered mice protection against both homologous viruses. VNAb induced by vaccines that included a MOKV glycoprotein gene cross-neutralized LBV, but not WCBV. We concluded that a single recombinant poxvirus-vectored vaccine including MOKV and RABV glycoprotein genes, should be a major addition to available rabies biologics and should offer broad protection against all of the lyssaviruses, except WCBV.<\/jats:p>","DOI":"10.1017\/s0950268807008965","type":"journal-article","created":{"date-parts":[[2007,6,22]],"date-time":"2007-06-22T13:36:18Z","timestamp":1182519378000},"page":"670-678","source":"Crossref","is-referenced-by-count":32,"title":["Cross-protective and cross-reactive immune responses to recombinant vaccinia viruses expressing full-length lyssavirus glycoprotein genes"],"prefix":"10.1017","volume":"136","author":[{"given":"J.","family":"WEYER","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.\u00a0V.","family":"KUZMIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.\u00a0E.","family":"RUPPRECHT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.\u00a0H.","family":"NEL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2007,6,22]]},"reference":[{"key":"S0950268807008965_ref037","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.24.9165"},{"key":"S0950268807008965_ref027","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.3.4.333"},{"key":"S0950268807008965_ref011","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(03)00036-7"},{"key":"S0950268807008965_ref035","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1993.1236"},{"key":"S0950268807008965_ref034","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1128\/JVI.73.1.225-233.1999","article-title":"Chimeric lyssavirus glycoprotein genes with increased immunological potential","volume":"73","author":"Jallet","year":"1999","journal-title":"Journal of Virology"},{"key":"S0950268807008965_ref033","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(97)00204-1"},{"key":"S0950268807008965_ref030","doi-asserted-by":"publisher","DOI":"10.1038\/312163a0"},{"key":"S0950268807008965_ref026","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/166.5.972"},{"key":"S0950268807008965_ref025","first-page":"25","article-title":"Antigenic characterization of the Bangui strain (ANCB-672d) of Lagos bat","volume":"131","author":"Sureau","year":"1980","journal-title":"Annals of Virology"},{"key":"S0950268807008965_ref023","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1972.21.959"},{"key":"S0950268807008965_ref021","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008120511752"},{"key":"S0950268807008965_ref019","first-page":"181","volume-title":"Laboratory Techniques in Rabies","author":"Smith","year":"1996"},{"key":"S0950268807008965_ref006","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2005.03.008"},{"key":"S0950268807008965_ref018","first-page":"88","volume-title":"Laboratory Techniques in Rabies","author":"Dean","year":"1996"},{"key":"S0950268807008965_ref016","doi-asserted-by":"publisher","DOI":"10.1016\/0166-0934(91)90129-N"},{"key":"S0950268807008965_ref015","first-page":"31","volume-title":"Vaccinia virus and poxvirology. Methods and Protocols","author":"Byrd","year":"2005"},{"key":"S0950268807008965_ref014","first-page":"16.16.1","volume-title":"Current Protocols in Molecular Biology","author":"Earl","year":"1998"},{"key":"S0950268807008965_ref008","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2005.03.009"},{"key":"S0950268807008965_ref002","unstructured":"2.\u00a0WHO. World Health Organization Expert Consultation on Rabies, 5\u20138 October 2004, First report. World Health Organization Technical report series 931. Geneva: World Health Organization, 2005, pp. 15\u201319. 105."},{"key":"S0950268807008965_ref001","first-page":"623","volume-title":"Virus taxonomy: the classification and nomenclature of viruses. The 8th Report of the International Committee on Taxonomy of Viruses","author":"Tordo","year":"2006"},{"key":"S0950268807008965_ref028","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.17.8096-8104.2001"},{"key":"S0950268807008965_ref038","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1128\/JVI.69.8.4957-4962.1995","article-title":"Cross-protection of mice against a global spectrum of rabies virus variants","volume":"69","author":"Lodmell","year":"1995","journal-title":"Journal of Virology"},{"key":"S0950268807008965_ref004","doi-asserted-by":"publisher","DOI":"10.3201\/eid0912.030374"},{"key":"S0950268807008965_ref013","doi-asserted-by":"crossref","first-page":"748","DOI":"10.2144\/98245bm10","article-title":"One step procedure for screening recombinant plasmids by size","volume":"24","author":"Beuken","year":"1998","journal-title":"BioTechniques"},{"key":"S0950268807008965_ref020","doi-asserted-by":"publisher","DOI":"10.3201\/eid1203.051306"},{"key":"S0950268807008965_ref040","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1128\/JVI.65.7.3429-3434.1991","article-title":"Role of CD4+ and CD8+ T cells in murine resistance to street rabies virus","volume":"65","author":"Perry","year":"1991","journal-title":"Journal of Virology"},{"key":"S0950268807008965_ref009","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.4.4.533"},{"key":"S0950268807008965_ref010","doi-asserted-by":"publisher","DOI":"10.3201\/eid1212.060764"},{"key":"S0950268807008965_ref029","doi-asserted-by":"publisher","DOI":"10.3201\/eid1212.060514"},{"key":"S0950268807008965_ref003","doi-asserted-by":"publisher","DOI":"10.3201\/eid0903.020252"},{"key":"S0950268807008965_ref007","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.7.3268-3276.2001"},{"key":"S0950268807008965_ref017","doi-asserted-by":"publisher","DOI":"10.1016\/0166-0934(81)90036-7"},{"key":"S0950268807008965_ref039","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)00357-0"},{"key":"S0950268807008965_ref041","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1128\/JVI.72.5.3711-3719.1998","article-title":"Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system","volume":"72","author":"Hooper","year":"1998","journal-title":"Journal of Virology"},{"key":"S0950268807008965_ref024","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(58)90127-5"},{"key":"S0950268807008965_ref022","first-page":"93","article-title":"Isolation of a rabies-related virus from the cerebrospinal fluid of a child with aseptic meningitis","volume":"3","author":"Familusi","year":"1972","journal-title":"African Journal of Medical Science"},{"key":"S0950268807008965_ref042","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.7.3374-3381.2002"},{"key":"S0950268807008965_ref031","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4613-1755-5_15"},{"key":"S0950268807008965_ref036","doi-asserted-by":"publisher","DOI":"10.1007\/BF01315415"},{"key":"S0950268807008965_ref032","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1993.1235"},{"key":"S0950268807008965_ref005","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-1702(03)00217-X"},{"key":"S0950268807008965_ref012","doi-asserted-by":"crossref","unstructured":"12.\u00a0 Weyer J . Immune responses to recombinant vaccinia viruses expressing full-length lyssavirus glycoprotein genes [Thesis]. Pretoria, South Africa: University of Pretoria, 2006, pp. 127\u2013156.","DOI":"10.1017\/S0950268807008965"}],"container-title":["Epidemiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0950268807008965","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T08:34:25Z","timestamp":1587630865000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0950268807008965\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,22]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0950268807008965"],"URL":"https:\/\/doi.org\/10.1017\/s0950268807008965","relation":{},"ISSN":["0950-2688","1469-4409"],"issn-type":[{"value":"0950-2688","type":"print"},{"value":"1469-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,22]]}}}